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Abstract
Background: Household transmission of influenza-like illness (ILI) may vary with viral and demographic
characteristics. We examined the effect of these factors in a population-based sample of adults with ILI.
Methods: We conducted a prospective cohort study in community-dwelling Australian adults nested within an
influenza vaccine effectiveness trial. On presentation with ILI, participants were swabbed for a range of respiratory
viruses and asked to return a questionnaire collecting details of household members with or without similar
symptoms. We used logistic and Poisson regression to assess the key characteristics of household transmission.
Results: 258 participants from multi-occupancy households experienced 279 ILI episodes and returned a
questionnaire. Of these, 183 were the primary case in the household allowing assessment of factors associated with
transmission. Transmission was significantly associated in univariate analyses with female sex (27% vs. 13%, risk ratio
(RR) = 2.13 (1.08, 4.21)) and the presence of a child in the house (33% vs. 17%, RR = 1.90 (1.11, 3.26)). The secondary
household attack proportion (SHAP) was 0.14, higher if influenza was isolated (RR = 2.1 (1.0, 4.5)). Vaccinated
participants who nonetheless became infected with influenza had a higher SHAP (Incidence RR = 5.24 (2.17, 12.6)).
Conclusions: The increased SHAP in households of vaccinated participants who nonetheless had confirmed
influenza infection supports the hypothesis that in years of vaccine mismatch, not only is influenza vaccine less
protective for the vaccine recipient, but that the population’s immunity is also lower.
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Background
Improved characterisation of the determinants of house-
hold transmission of influenza-like illness (ILI) remains
an important public health priority, particularly in light
of the past decade’s events in which we have witnessed
the emergence of severe-acute-respiratory-syndrome
(SARS) and the 2009 H1N1 influenza pandemic. The
evidence base for pandemic influenza public health
interventions such as home-quarantine, provision of
antiviral agents for post-exposure prophylaxis, school-
closure and vaccination builds upon an appropriate
understanding of the patterns and timing of infection
within the household unit [1-6].
While influenza viruses, rhinoviruses (HRVs), adeno-
viruses, respiratory syncytial virus (RSV) and parainflu-
enza viruses (PIVs) are the most common aetiological
agents in acute-respiratory-infection (ARI) episodes
[7,8], in 30 – 40% of all ARI episodes no known respira-
tory virus can be identified [9,10]. This is despite discov-
ery of a number of previously undescribed viruses since
2001 from clinical specimens from the human respira-
tory tract (human metapneumovirus [11], SARS corona-
virus [12], coronavirus NL63 [13], coronavirus HKU1
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[14], novel rhinoviruses [8], human bocaviruses [15] and
K1 and WU polyomaviruses [16,17]).
Reflecting the need to improve our understanding of
household transmission of ARI, the literature examining
factors associated with household transmission of influ-
enza [6,18-21] has expanded significantly since the 2009
H1N1 influenza pandemic [22-31], including a system-
atic review and meta-analysis [32]. Donnelly et al. esti-
mated the serial interval for all ILI (without laboratory
confirmation) from case reports during the 2009
pandemic [25]. Only two studies of which we are aware
explicitly consider the impact of virus type on infec-
tiousness. Principi et al. found less onwards transmission
to household members from influenza-negative than
influenza-positive children presenting to a hospital
emergency department [33]. Similarly, in a cohort study
of ARI in young children, Lambert et. al. observed sig-
nificant heterogeneity in the proportion of participants’
households in which one or more illness events were
observed (ranging from 13% for isolation of hMPV from
the child to 61% for isolation of influenza) [34].
Here we report on the household transmission of
a range of viruses in a cohort study of healthy,
community-dwelling adults reporting symptoms of
influenza-like illness (ILI). The study population was
sourced from a large, industry sponsored placebo-
controlled phase IV efficacy trial of a licensed seasonal
trivalent influenza vaccine (Fluvax W, CSL Ltd), con-
ducted prior to the 2009 pandemic between March and
November 2008. In a previous article [35] we have
described the viral aetiology of ILI in the cohort, and
examined the influence of virus type, host and spatio-
temporal factors on disease symptomatology.
Methods
Subject recruitment and selection
Full details of subject recruitment and selection for the
primary phase IV vaccine efficacy trial have been
described previously [35]. Briefly, across 23 study sites
in Australia and New Zealand, 7544 healthy adults aged
≥18 to <65 years were recruited for a placebo-
controlled trial of a licensed trivalent influenza vaccine
(FluvaxW, CSL Ltd) in 2008 (Clinicaltrials.gov
#NCT00562484). Study participants were randomized
to receive either placebo or vaccine in a 1:2 ratio prior
to the southern hemisphere 2008 influenza season.
From an available pool of 5624 participants from the
primary study at 12 study sites, we consider the 581 per-
sons (adults) who experienced at least one ILI episode –
meeting the case definition of at least one respiratory
symptom (cough, sore throat, runny nose or nasal con-
gestion) and at least one systemic symptom (fever (oral
temperature ≥ 37.8°C), feverishness, chills or myalgia)
[35], and who provided written informed consent for
participation in the nested cohort-study which required
contribution of a valid biological sample (COPANTM
dry flocked swab). Samples were tested for a range of re-
spiratory viruses using a combination of multiplexed
and uniplexed conventional and real-time polymerase
chain reaction (PCR) assays [35]. Of those, 258 were
members of multi-occupancy households, allowing in-
vestigation of transmission within the household. Using
a non-specific and sensitive ILI definition, they reported
an episode of ILI on 279 occasions. For each episode
they returned a study questionnaire (Additional file 1)
detailing respiratory symptoms (see [35] for details),
health seeking behaviour (health care provider consulta-
tions, hospital admission, time off work), household
characteristics (number of adults (≥18 years) and chil-
dren (<18 years)) and temporally associated symptoms
of ILI (if any) in other household members. From
herein, we consider the illness episode as the primary
unit of analysis.
The primary phase IV vaccine efficacy trial and nested
sub-study were approved by Ethics Committees at all
study sites: Royal Children’s Hospital Ethics in Human Re-
search Committee (Victoria), Princess Margaret Hospital
for Children, Ethics Committee (Western Australia),
Redcliff-Caboolture Health Service District (Queensland),
Human Research Ethics Committee Network (Tasmania),
Children, Youth and Women’s Health Service Research
Ethics Committee (South Australia), Bellberry Ltd (South
Australia, Queensland), Cairns District Health Service
Cairns Base Hospital Ethics Committee (Queensland).
Outcome measures and analysis
Virology results were classified into 5 virus groups [35]:
influenza (influenza A, influenza B), coronaviruses (OC43,
229E, NL63, HKU1), picornaviruses, other viruses (para-
influenza viruses (1, 2, 3), adenoviruses, human metapneu-
movirus (hMPV), bocaviruses, RSV and KI and WU
polyomaviruses) or none, where none indicates that no
‘tested-for’ virus was detected in the participant’s sample,
as opposed to a missing sample or inconclusive result.
Study participants’ vaccination status (as determined by
the primary phase IV trial intervention), physical location
(i.e. study site), and socio-demographic characteristics
were also recorded.
The relevant outcome measure for this sub-analysis was
evidence of transmission within households based on
experience of symptomatic illness in at least one other
member of the study participant’s household. Study parti-
cipants were asked to complete the diary on the day fol-
lowing cessation of their own symptoms. They recorded
the date of onset of symptomatic ILIs in household mem-
bers from between 14 days prior to the study participant’s
illness through to the day of diary completion. Note that
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the primary case in the household may or may not be the
study participant.
For household ILI events in which the participant was
the primary case (183 of 279), transmission may or may not
have occurred in the household and so it is statistically valid
to develop univariate and multivariate explanatory models.
For participants who reported recurrent ILI episodes during
the study in which the same virus was isolated, we exclude
all but the first episode. Events with co-introduction,
defined as onset of symptoms in the participant and one or
more household members on the same day, were also
excluded. Following these exclusions, 177 episodes
remained for analysis.
For household ILI events in which the participant was
not the primary case (95 of 279), while we do know who
the introducer was for these events (via the question-
naire data), other household ILI events initiated by that
introducer that did not involve the participant are unob-
served. That is, any events in which a child (or for that
matter, any other adult member of the household) intro-
duced an infection that did not infect the study partici-
pant are not captured by the study protocol. This
observation necessitates the exclusion of all household
ILI events in which the participant was not the primary
case from the analyses.
In the one remaining household ILI event, the status
of the participant (primary or not) was unknown, so the
episode was excluded from the analysis.
For the 177 episodes in which the participant was the
primary case, logistic regression models were used to ex-
plore associations between host, demographic or virus
variables with any observation of within-household trans-
mission (outcome variable = transmission in household
for each recorded ILI episode in a study participant). The
secondary household attack proportion (SHAP) was cal-
culated as the proportion of potentially exposed house-
hold members (assumed susceptible) experiencing illness,
averaged over all recorded episodes. We present descrip-
tive statistics for the SHAP and its variation by virus, par-
ticipant and demographic variables. Poisson regression
models were used to assess the influence of virus, partici-
pant and demographic variables on the number of second-
ary cases within a given household, offset against the
number of potentially exposed household members (out-
come variable = number of secondary cases in household
for each recorded ILI episode in a study participant).
Vaccination status of participants was not included in
the primary logistic and Poisson statistical analyses due
to its known mitigating effect on the likelihood of influ-
enza acquisition [35]. Investigation of the influence of
prior immunisation on influenza transmission in ‘break-
through cases’ was explored in a secondary analysis by
inclusion of a statistical interaction term between vac-
cination and influenza-identification status.
We make an empirical calculation of the mean time
between the onset of symptoms in the primary case and
the onset of symptoms in the household contacts (the
serial interval), for all household ILI events, events in
which the participant was the primary case, and events
in which influenza was isolated from the participant’s
virological sample.
All statistical analyses were conducted in Stata/IC 11.1.
Results
Figure 1 reports characteristics of the 258 multi-
occupancy households in which transmission did and
did not occur. 28 study participants reported two or
more ILI episodes during the course of the study. For
two participants, who both experienced two episodes, pi-
cornavirus was isolated on both occasions. We only re-
tain the first episode for each participant.
The distribution of household size is dramatically dif-
ferent based on the absence or presence of children
within the household (Figure 2). In households without
children, the distribution is left-skewed (mean household
size = 3.02, standard deviation (SD) = 1.18, skewness =
1.45), while in households with children there is minimal
skew (mean household size = 4.18, SD = 1.11, skewness =
0.103).
Factors associated with any transmission within
the household
The study participant was the primary case in 183 of the
279 recorded household ILI events. One re-introduction
of picornavirus into the household and five co-
introductions were recorded, leaving 177 episodes for
analysis. Transmission occurred in 39 (22.0%) episodes.
Stratifying by presence of child (Figure 1), transmission
occurred in 17 of 54 (31.5%) households in which at
least one child was present and 22 of 123 (17.9%) house-
holds without children, a risk-ratio (RR) of 1.76 (1.02,
3.04), p = 0.045.
Female sex of the participant was associated with
increased transmission: 30 of 108 (27.8%) episodes in
women compared to 9 of 69 (13.0%) episodes in men, a
risk ratio of 2.13 (1.08, 4.21), p = 0.021. The association
with female sex remained (at borderline significance)
when restricted to households without children (123 epi-
sodes): 23.3% transmission compared to 10.0% for males,
a risk ratio of 2.33 (0.919, 5.90), p = 0.059. The risk ratio
for female sex in households with children (54 episodes)
was 1.76 (0.668, 4.66), p = 0.224.
Table 1 summarizes the descriptive statistics (and lo-
gistic model results) associated with presence or absence
of transmission in the household for the 177 household
ILI events in which the participant was the primary case.
There is marked co-linearity between the variables
‘presence of child in household’, ‘age-category’ and
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Figure 1 Breakdown of households, by introducing-status of participant, demographic characteristics and evidence of
within-household transmission.
Figure 2 Household size distribution by presence of children (279 episodes).
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‘household size’. For example, respondents aged 35 –
44 years had significantly greater odds of having a child
in the household than those aged 18 – 24 years (OR
53.2 (13.0, 217)), while no participant aged more than
55 years lived with a child. The relationship between the
household size distribution and presence or absence of
children is depicted in Figure 2. We retained ‘presence
of child in household’ in the final multivariate model for
transmission due to its strong predictive role, intuitive
appeal, presumed causal role in our observed (univari-
ate) association with age-category, and previous research
indicating an association between transmission and chil-
dren [18,22,23,29,36]. In the multivariate model, the
observed increased risk of transmission with female sex
remains (OR = 2.45 (1.01, 5.93), p = 0.047). Presence of
children in the household is both the strongest and most
statistically significant factor associated with transmis-
sion (OR = 2.63 (1.18, 5.88), p = 0.018).
Factors associated with the number of secondary
household infections
Within 258 multi-occupancy households, 177 primary-
participant introductions gave rise to 54 secondary cases
among 391 potentially exposed individuals, a secondary
household attack rate (SHAP) of 0.138. Of 102 exposed
children, 22 developed ILI (SHAP = 0.216) compared to
32 of 289 adults (SHAP = 0.110), a risk-ratio of 1.95
(1.19, 3.19), p = 0.012. The adult SHAP did not differ by
presence of children in the household (0.117 vs. 0.109,
RR = 1.07 (0.486, 2.35)).
In households in which the participant was female, 41
secondary infections were reported among 238 exposed
household members (SHAP = 0.172), compared with 13
secondary cases among 153 contacts in households in
which the participant was male (SHAP = 0.085), a risk-
ratio of 2.03 (1.12, 3.66), p = 0.016 (2-sided Fisher’s exact).
In households with children, 27 secondary infections
were reported among 162 exposed household members
(SHAP = 0.167), compared with 27 secondary cases
among 229 contacts in households without children
(SHAP = 0.118), a risk-ratio of 1.41 (0.863, 2.32), p = 0.182.
A multivariate Poisson regression model (Table 2) was
used to consider the influence of virus group and demo-
graphic characteristics on the number of reported sec-
ondary cases within a given household, offset against the
number of potentially exposed household members. In
correspondence with the logistic regression model for
transmission, we include presence of children in the
Table 1 Predictors of transmission (participant primay case, 177 household ILI events)






OR (95% CI) p OR (95% CI) P
Virus Group (cf none detected) None 20 of 95 (21.1%) 1.00 (def) - 1.00 (def) -
Picornavirus 10 of 40 (25.0%) 1.25 (0.524, 2.98) 0.615 0.996 (0.398, 2.49) 0.994
Influenza 5 of 17 (29.4%) 1.56 (0.493, 4.95) 0.448 1.87 (0.552, 6.36) 0.314
Coronavirus 3 of 6 (50.0%) 3.75 (0.703, 20.0) 0.122 2.43 (0.409, 14.4) 0.330
Other 0 of 8 (0.00%) - - - -
Sex (cf male) Male 9 of 69 (13.0%) 1.00 (def) - 1.00 (def) -
Female 30 of 108 (27.8%) 2.56 (1.13, 5.81) 0.024 2.45 (1.01, 5.93) 0.047
Smoking (cf not current smoker) Not current smoker 36 of 161 (22.4%) 1.00 (def) - 1.00 (def) -
Current smoker 3 of 12 (25.0%) 1.16 (0.298, 4.50) 0.833 1.40 (0.319, 6.12) 0.658
Age (cf 18–24 years) 18-24 years 9 of 47 (19.2%) 1.00 (def) - Not included -
25-34 years 5 of 28 (17.9%) 0.918 (0.274, 3.08) 0.890 Not included -
35-44 years 15 of 37 (40.5%) 2.88 (1.08, 7.66) 0.034 Not included -
45-54 years 6 of 36 (16.7%) 0.844 (0.270, 2.64) 0.771 Not included -
55-64 years 4 of 29 (13.8%) 0.676 (0.188, 2.43) 0.549 Not included -
Household size (cf size 2) 2 14 of 64 (21.9%) 1.00 (def) - Not included -
3 4 of 44 (9.09%) 0.357 (0.109, 1.17) 0.089 Not included -
4 11 of 46 (23.9%) 1.22 (0.456, 2.76) 0.801 Not included -
5 8 of 17 (47.1%) 3.17 (1.03, 9.75) 0.044 Not included -
6 2 of 3 (66.7%) 7.14 (0.602, 84.7) 0.119 Not included -
7 0 of 3 (0.00%) - - Not included -
Presence of child (cf no children in house) No child in house 22 of 123 (17.9%) 1.00 (def) - 1.00 (def) -
At least one child in house 17 of 54 (31.5%) 2.11 (1.01, 4.41) 0.047 2.63 (1.18, 5.88) 0.018
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household rather than age-category or household size in
the model. Consistent with the findings from the multi-
variate model for transmission and the univariate SHAP
analyses, we observe a significant effect of sex. Presence
of children in the household, while suggestive of an in-
crease in the SHAP, is not statistically significant. In
contrast to the analysis on transmission, we observe a
positive association for the number of secondary cases
with isolation of influenza (Incidence Risk Ratio (IRR) =
2.11 (0.992, 4.49), p = 0.052). Note that if, as an alterna-
tive to “no virus detected”, we use picornavirus as the
reference group, we again find a positive association with
isolation of influenza (IRR = 2.25 (0.960, 5.29, p = 0.062)
in a multivariate model, full results not shown).
In a secondary analysis, we considered the influence of
prior vaccination on the reported number of secondary
household cases among participants testing positive
for influenza compared with all other participants. In a
Poisson model for secondary attacks including a statis-
tical interaction between influenza detection (true/false)
and vaccination status (placebo/vaccine), the IRR for
influenza positive cases in those receiving placebo
was 1.69 (0.421, 6.80), p = 0.459. The factor increase
(interaction term) for the IRR for vaccinated participants
was 3.10 (0.608, 15.8), p = 0.174, yielding a net IRR for
vaccinated influenza-positive participants relative to vac-
cinated influenza-negative participants of 5.24 (2.17,
12.6), p < 0.001).
Serial interval
Under the simplifying assumption that the introducer of
infection into the household is responsible for all subse-
quent infections, we may calculate an empiric serial
interval, the time from symptom onset in one individual
until symptom onset in another. We first consider infec-
tions to be related if symptoms are reported within
14 days following onset in the primary case. Across all
virus-type isolations, we calculate a mean serial interval
of 6.0 days (SD = 3.6) for all household ILI events (where
the study participant was the primary case or otherwise),
and 5.1 days (SD = 3.2) for the events in which the par-
ticipant was the primary case. For the five events in
which the primary participant had virologically con-
firmed influenza and transmission occurred, the mean
serial interval was 4.5 days (SD = 1.6). If we limited the
maximum serial interval to seven days, the mean was
reduced to 4.0 days (SD = 1.7) for all household ILI
events and 3.9 days (SD = 1.9) for events in which the
Table 2 Predictors of the number of secondary cases in the household, offset against the number of potentially
exposed household members (participant primay case, 177 household ILI events)




IRR (95% CI) p
Virus Group (cf none detected) None 0.129 (95) 1.00 (def) -
Picornavirus 0.143 (40) 0.937 (0.475, 1.85) 0.851
Influenza 0.238 (17) 2.11 (0.992, 4.49) 0.052
Coronavirus 0.357 (6) 1.80 (0.670, 4.85) 0.243
Other 0.000 (8) - -
Sex (cf male) Male 0.085 (69) 1.00 (def) -
Female 0.172 (108) 2.12 (1.10, 4.09) 0.025
Smoking (cf not current smoker) Not current smoker 0.136 (161) 1.00 (def) -
Current smoker 0.250 (12) 1.91 (0.738, 4.94) 0.183
Age (cf 18–24 years) 18-24 years 0.106 (47) Not included -
25-34 years 0.115 (28) Not included -
35-44 years 0.235 (37) Not included -
45-54 years 0.095 (36) Not included -
55-64 years 0.100 (29) Not included -
Household size (cf size 2) 2 0.219 (64) Not included -
3 0.068 (44) Not included -
4 0.123 (46) Not included -
5 0.206 (17) Not included -
6 0.200 (3) Not included -
7 0.000 (3) Not included -
Presence of child (cf no children in house) No children in house 0.118 (123) 1.00 (def) -
At least one child in house 0.167 (54) 1.51 (0.864, 2.65) 0.147
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participant was the primary case. No gaps of greater
than seven days occurred for the five events in which
the primary participant had virologically confirmed in-
fluenza and transmission occurred.
Sensitivity analysis
In our main analysis, we made two assumptions that we
now subject to a sensitivity analysis. Of the 183 events
in which our participant was the primary case, 6 were
classified as co-introductions as (at least) one other
household member recorded symptoms beginning on
the same day. As the latent period for respiratory infec-
tions may vary from individual to individual, here we ex-
clude a further 4 episodes in which there was a 1 day
interval from onset of symptoms in the study participant
to onset of symptoms in another household member.
The resulting multivariate models (equivalent to Tables 1
and 2) are materially unchanged, with the expected
slight reduction in statistical power (data not shown).
A second assumption made was that, for participants
who reported multiple ILI episodes during the study
period, we only excluded the latter ILI episode where
the same respiratory pathogen was isolated on both
occasions. However, if we conservatively exclude all ILI
episodes except for the first (10 episodes excluded (by
virus type: 6 “none”, 1 “picornavirus”, 2 “influenza”, 1
“coronavirus”)), again we find no material change in ei-
ther the logistic or Poisson analyses (data not shown).
Discussion
This study, notable in its consideration of a broad range
of respiratory pathogens in addition to influenza,
demonstrates that household transmission of ILI is most
strongly associated with host and demographic factors:
female sex and the presence of children within the
household (Tables 1 and 2).
The observation that female sex may be associated
with increased transmission in the absence of children
(RR = 2.33 (0.919, 5.90), p = 0.059) is novel, perhaps sug-
gesting that females are fundamentally more infectious,
and not simply more connected to children (in terms of
both their susceptibility compared with males if a child
introduces infection, and their infectiousness to children
if they are the primary household case). Behavioural dif-
ferences whilst ill may drive such an observation. Alter-
natively, mechanisms by which influenza pathogenesis is
sex dependent have been investigated [37]; whether or
not differences extend to infectiousness and susceptibil-
ity is not clear. Barbara et al. have recently identified
that the reporting of respiratory symptoms may be
linked with risk perception [38] and hence gender
[39]. Clearly, we cannot exclude the possibility of
gender difference in the reporting of within household
transmission.
The association between transmission and the pres-
ence of children within the household is consistent with
many other studies [18,22,23,29,36]. The logistic and
Poisson model findings (Tables 1 and 2) are consistent
with an increased susceptibility for children. This is fur-
ther supported by the observed increased SHAP in chil-
dren compared to adults (0.216 compared to 0.110, a
risk-ratio of 1.95 (1.19, 3.19). The SHAP in adults did
not differ by whether or not their household contained
children, suggesting that other ‘indirect’ effects of chil-
dren are less likely. As our study design limited the ana-
lysis to household events with an adult introducer, we
were unable to assess the hypothesis that children may
be more infectious than adults.
Our Poisson regression analysis on the number of sec-
ondary cases given that the participant was the primary
case (Table 2) indicates that isolation of influenza in the
introducer of infection to the household is associated
with an increase in the number of secondary cases. We
explored this finding more deeply using a statistical
interaction model. While somewhat limited by sample
size, we found that in placebo recipients identification of
influenza was not significantly associated with an in-
crease in the number of secondary cases (IRR = 1.69
(0.421, 6.80), p = 0.459), while in vaccine recipients the
IRR (relative to identification of any other virus, includ-
ing ‘none’) was 5.24 (2.17, 12.6), p < 0.001. Note that our
previous analysis confirms that vaccination is associated
with a reduced probability of influenza virus identifica-
tion [35]. Additionally, ‘breakthrough’ influenza cases
have similar symptoms compared to unvaccinated indi-
viduals [35]. We therefore suggest that our finding of
increased transmission may be explained by infection
with an influenza virus mismatched to the vaccine-strain
(known to be in circulation during the year of study
[40]), which furthermore may be relatively antigenically
novel and to which household members may be
expected to have heightened susceptibility. With no viro-
logical samples available from other household members
and the small number of vaccinated participants who
were infected with influenza we are unable to explore
this hypothesis further.
Across all virus types isolated and all household ILI
events, and assuming that all secondary cases within the
household are directly infected by the introducer, we cal-
culate a serial interval of 6.0 days. Restricting to events
in which the participant was the primary case and in
which influenza was isolated, we calculate a serial inter-
val of 4.5 days. This simple approach, as taken by others
[22,29], cannot account for two important factors: com-
munity importation and infection of household members
by other non-introducing members (i.e. tertiary cases).
While others have partially accounted for these effects
[25,29,41], a mechanistically-motivated statistical model
McCaw et al. BMC Infectious Diseases 2012, 12:345 Page 7 of 10
http://www.biomedcentral.com/1471-2334/12/345
is required to fully account for such possibilities, for ex-
ample as introduced by Cauchemez et al. [23] who
determined a serial interval for influenza of 2.6 days
(SD = 1.3) compared to 2.9 days if calculated directly
from empirical observations. With just 5 events, applica-
tion of these more advanced model-based techniques is
not justified for our data.
Of primary interest for this sub-analysis focussed on
transmission is the complication introduced by the mon-
itoring and assessment of ILI in an individual rather
than a household. Ideally, a protocol such as that sug-
gested by Klick et al. would have been employed [42].
The lack of virological assessment of household second-
ary cases and the broad nature of the question used to
establish the secondary case count in each house also
contributes to uncertainty with regards to our assign-
ment of temporally associated ILI to within-household
transmission. Both of these limitations were an unavoid-
able consequence of the nesting of the data-collection
protocol within a randomized placebo-controlled trial.
Furthermore, due to the requested timing for comple-
tion of the questionnaire, we cannot exclude the possi-
bility that late onset of secondary (or tertiary etc.) cases
may have been missed, particularly if a participant’s ex-
perience of symptoms was of short duration. Similarly,
because the study protocol and analyses effectively as-
sume that individuals are infectious until the end of their
symptoms, any systematic differences (by virus type) in
this relationship may influence the results. However the
prompt to return the diary upon symptom cessation was
in an effort to ensure timely reporting of questionnaire
information to minimise recall bias. Conversely, our
Poisson model implicitly assumes independence among
household members, attributing all household infections
to the primary case. More advanced model based meth-
ods that account for tertiary (and subsequent) cases and
community introduction would be warranted with more
complete data sources.
As with all protocols based purely on symptomatic
presentation (as opposed to active surveillance for non-
clinical signs of infection such as virological or immuno-
logical measures [24,42]), we are unable to account for
potential sub-clinical infection routes, with potential im-
pact for our assessment of whether or not transmission
did occur, the primary case status of our participants
and determination of the size of the susceptible pool
within a given household. Conversely, taking a non-
simulation approach to analysis, we are unable to dis-
count our estimate for the SHAP due to the effects of
community introduction into the household, or account
for community introduction and tertiary cases in our es-
timate for the serial interval [23].
Our study sample had an over-representation of
females (166 of 258 (64.3%) individuals for the 279
captured episodes; 105 of 167 (62.9%) individuals for the
177 primary-participant introductions). Furthermore, it
should be noted that the study population were origin-
ally volunteers in a randomized controlled trial and as
such more likely to represent a group who were more
concerned with their health than the general population.
Eligibility was restricted to healthy adults without recog-
nized risk factors for severe influenza infection.
Conclusions
In the context of a literature focussed on the transmis-
sion characteristics of laboratory confirmed influenza,
our study is the only one that we know of to systematic-
ally explore the relationship between transmission and
virus aetiology. The analyses suggest that influenza is
more transmissible than other causative agents of ILI, at
least when introduced to the household by an adult.
Host and demographic factors are also of importance.
Further studies combining active surveillance of all
household members with specimen collection and test-
ing for a range of respiratory pathogens are warranted to
elucidate these relationships.
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